FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042239874> ?p ?o ?g. }

• W2042239874 endingPage "426" @default.
• W2042239874 startingPage "421" @default.
• W2042239874 abstract "WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Lapatinib is an orally administered tyrosine kinase inhibitor indicated for use in combination with capecitabine to treat advanced or metastatic breast cancers that overexpress ErbB2 in patients previously treated with anthracyclines, taxanes and trastuzumab. • In vitr o studies have suggested that lapatinib is metabolized primarily by CYP3A4, that it is a substrate of the efflux transporter ABCB1, and that it is a modest inhibitor of both CYP3A4 and ABCB1. • However, no data regarding the in vivo metabolism of lapatinib have as of yet been reported. WHAT THIS STUDY ADDS • The in vivo pharmacokinetics of lapatinib in healthy subjects was determined in the presence of a potent inhibitor (ketoconazole) or inducer (carbamazepine) of CYP3A4. • The results indicated that systemic exposure to lapatinib was significantly altered by inhibition or induction of CYP3A4. • Thus, dose adjustments may be required when lapatinib is administered orally concomitantly with drugs that potently alter CYP3A4 activity. AIMS To characterize the impact of potent CYP3A4 inhibition and induction on lapatinib pharmacokinetics. METHODS Two studies were conducted in healthy subjects. One study examined the effect of ketoconazole 200 mg b.i.d. for 7 days on a single 100‐mg dose of lapatinib in 22 healthy subjects. The other study examined the effect of carbamazepine titrated up to 200 mg b.i.d. over 20 days on a single 250‐mg dose of lapatinib in 24 healthy subjects. RESULTS Ketoconazole altered lapatinib AUC, C max and half‐life, with geometric mean [95% confidence interval (CI)] increases of 3.57‐fold (3.07, 4.15), 2.14‐fold (1.74, 2.64) and 1.66‐fold (1.50, 1.84), respectively, but had no effect on absorption rate. Carbamazepine altered lapatinib AUC, C max and absorption rate, with geometric mean (95% CI) decreases of 72% (68, 77), 59% (49, 66) and 28% (4, 46), respectively, but had no effect on half‐life. CONCLUSIONS Systemic exposure to lapatinib was significantly altered by potent inhibition and induction of CYP3A4. Dose adjustments may be required when lapatinib is administered with orally administered drugs that potently alter the activity of this enzyme." @default.
• W2042239874 created "2016-06-24" @default.
• W2042239874 creator A5001448137 @default.
• W2042239874 creator A5007441935 @default.
• W2042239874 creator A5013291304 @default.
• W2042239874 creator A5044614018 @default.
• W2042239874 creator A5069858853 @default.
• W2042239874 creator A5082477859 @default.
• W2042239874 date "2009-04-01" @default.
• W2042239874 modified "2023-10-18" @default.
• W2042239874 title "Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects" @default.
• W2042239874 cites W1578896110 @default.
• W2042239874 cites W1967763477 @default.
• W2042239874 cites W1972499303 @default.
• W2042239874 cites W2024145840 @default.
• W2042239874 cites W2056565974 @default.
• W2042239874 cites W2071728786 @default.
• W2042239874 cites W2073975093 @default.
• W2042239874 cites W2106755661 @default.
• W2042239874 cites W2120869872 @default.
• W2042239874 cites W2132001275 @default.
• W2042239874 cites W2155974380 @default.
• W2042239874 doi "https://doi.org/10.1111/j.1365-2125.2009.03370.x" @default.
• W2042239874 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2679105" @default.
• W2042239874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19371315" @default.
• W2042239874 hasPublicationYear "2009" @default.
• W2042239874 type Work @default.
• W2042239874 sameAs 2042239874 @default.
• W2042239874 citedByCount "54" @default.
• W2042239874 countsByYear W20422398742012 @default.
• W2042239874 countsByYear W20422398742013 @default.
• W2042239874 countsByYear W20422398742014 @default.
• W2042239874 countsByYear W20422398742015 @default.
• W2042239874 countsByYear W20422398742016 @default.
• W2042239874 countsByYear W20422398742017 @default.
• W2042239874 countsByYear W20422398742019 @default.
• W2042239874 countsByYear W20422398742020 @default.
• W2042239874 countsByYear W20422398742021 @default.
• W2042239874 countsByYear W20422398742022 @default.
• W2042239874 crossrefType "journal-article" @default.
• W2042239874 hasAuthorship W2042239874A5001448137 @default.
• W2042239874 hasAuthorship W2042239874A5007441935 @default.
• W2042239874 hasAuthorship W2042239874A5013291304 @default.
• W2042239874 hasAuthorship W2042239874A5044614018 @default.
• W2042239874 hasAuthorship W2042239874A5069858853 @default.
• W2042239874 hasAuthorship W2042239874A5082477859 @default.
• W2042239874 hasBestOaLocation W20422398741 @default.
• W2042239874 hasConcept C109650736 @default.
• W2042239874 hasConcept C112705442 @default.
• W2042239874 hasConcept C118552586 @default.
• W2042239874 hasConcept C121608353 @default.
• W2042239874 hasConcept C126322002 @default.
• W2042239874 hasConcept C149151106 @default.
• W2042239874 hasConcept C150903083 @default.
• W2042239874 hasConcept C16005928 @default.
• W2042239874 hasConcept C207001950 @default.
• W2042239874 hasConcept C2777329042 @default.
• W2042239874 hasConcept C2778186239 @default.
• W2042239874 hasConcept C2778820342 @default.
• W2042239874 hasConcept C2779253243 @default.
• W2042239874 hasConcept C2779548794 @default.
• W2042239874 hasConcept C2779786085 @default.
• W2042239874 hasConcept C2781064554 @default.
• W2042239874 hasConcept C526171541 @default.
• W2042239874 hasConcept C530470458 @default.
• W2042239874 hasConcept C62231903 @default.
• W2042239874 hasConcept C71924100 @default.
• W2042239874 hasConcept C86803240 @default.
• W2042239874 hasConcept C97320921 @default.
• W2042239874 hasConcept C98274493 @default.
• W2042239874 hasConceptScore W2042239874C109650736 @default.
• W2042239874 hasConceptScore W2042239874C112705442 @default.
• W2042239874 hasConceptScore W2042239874C118552586 @default.
• W2042239874 hasConceptScore W2042239874C121608353 @default.
• W2042239874 hasConceptScore W2042239874C126322002 @default.
• W2042239874 hasConceptScore W2042239874C149151106 @default.
• W2042239874 hasConceptScore W2042239874C150903083 @default.
• W2042239874 hasConceptScore W2042239874C16005928 @default.
• W2042239874 hasConceptScore W2042239874C207001950 @default.
• W2042239874 hasConceptScore W2042239874C2777329042 @default.
• W2042239874 hasConceptScore W2042239874C2778186239 @default.
• W2042239874 hasConceptScore W2042239874C2778820342 @default.
• W2042239874 hasConceptScore W2042239874C2779253243 @default.
• W2042239874 hasConceptScore W2042239874C2779548794 @default.
• W2042239874 hasConceptScore W2042239874C2779786085 @default.
• W2042239874 hasConceptScore W2042239874C2781064554 @default.
• W2042239874 hasConceptScore W2042239874C526171541 @default.
• W2042239874 hasConceptScore W2042239874C530470458 @default.
• W2042239874 hasConceptScore W2042239874C62231903 @default.
• W2042239874 hasConceptScore W2042239874C71924100 @default.
• W2042239874 hasConceptScore W2042239874C86803240 @default.
• W2042239874 hasConceptScore W2042239874C97320921 @default.
• W2042239874 hasConceptScore W2042239874C98274493 @default.
• W2042239874 hasIssue "4" @default.
• W2042239874 hasLocation W20422398741 @default.
• W2042239874 hasLocation W20422398742 @default.
• W2042239874 hasLocation W20422398743 @default.
• W2042239874 hasLocation W20422398744 @default.

• next